PTI explains strength and BCS-based biowaivers

Pharmaceutical Training International (PTI), the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, is launching a series of easy-access and cost–effective webinar e-courses to guide pharma professionals through the industry challenges they face.

The first two webinars will provide advice on making applications for biowaivers in the EU and US, each including live question and answer sessions. By equipping themselves with this knowledge, participants will be able to push products to market faster and with less hassle and expense.

Careful consideration is required in bringing a generic pharmaceutical entity to market, including the strategic use of biowaivers to by-pass the need for expensive and time-consuming clinical studies. Industry expert Jean-Michel Cardot, Professor of the Department of Biopharmaceutics and Pharmaceutical Technology, Universite d’Auvergne, will guide participants through two webinars on this subject, the first on Strength Biowaivers, at 2:30 PM on Monday 30^th November, and the second on BCS-based Biowaivers at 2:30 PM on Monday 7^th December.

These two webinar e-courses will provide both new and experienced personnel with a thorough grounding in biowaivers, including the types of biowaiver available, requirements in the EU and US, the application process, and common pitfalls encountered. In each, Professor Cardot will examine the optimal strategy to implement a biowaiver, and hold a comprehensive question and answer session to address specific queries. Participants will gain the confidence and skills to implement a strategic approach to biowaiver applications for fast tracking their products through their organisations’ pipeline.

“Every member of our team aims to provide the very best training to (bio)pharmaceutical professionals,” comments PTI’s Managing Director, Rosie Bernard.  “This new series of webinar e-courses will focus on ‘hot topics’ that need to be addressed by the industry to ensure new drugs are successfully brought to market. Our biowaiver webinars are designed for both new and experienced personnel alike, and will provide participants with the expertise to make successful biowaiver applications, helping them accelerate their drugs’ route to market.”

Learn more, and register for these webinar e-courses